BeOne Medicines
ONC
#649
Rank
NZ$61.79 B
Marketcap
NZ$558.42
Share price
-2.56%
Change (1 day)
57.04%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$1.76 Billion

According to BeOne Medicines's latest financial reports the company's total debt is NZ$1.76 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BeOne Medicines - Total debt on balance sheet (from 2014 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$1.91 B30.18%
2023-12-31NZ$1.47 B56.51%
2022-12-31NZ$0.93 B-7.59%
2021-12-31NZ$1.01 B30.58%
2020-12-31NZ$0.77 B89.13%
2019-12-31NZ$0.41 B39.23%
2018-12-31NZ$0.29 B27.53%
2017-12-31NZ$0.23 B829.49%
2016-12-31NZ$24.95 M-17.84%
2015-12-31NZ$30.37 M71.96%
2014-12-31NZ$17.66 M-46.96%
2013-12-31NZ$33.29 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ$0.68 B-61.23%๐Ÿ‡บ๐Ÿ‡ธ USA